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The therapeutic use of probiotics for supporting the antibiotic action against gastrointestinal disorders is
a current trend and emerging applications have gained popularity because of their support for various
microbiological activities in digestive processes. Microorganisms isolated from keﬁr with great probiotic
properties, in addition to high resistance to harsh environmental conditions, have been widely
researched. Administration of probiotic yeasts offers a number of advantages, when compared to bac-
teria, because of particular characteristics as their larger cell size. In the present study, 28 strains of
Saccharomyces cerevisiae were isolated, after in vitro digestion of keﬁr-fermented milk, and identiﬁed by
molecular based approaches. A screening was performed to determine important quality requirements
for probiotics including: antagonistic and antioxidant activities, b-galactosidase synthesis, autoag-
gregation, surface hydrophobicity and adhesion to epithelial cells. The results showed strains: with
antagonistic activity against microbial pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa,
Staphylococcus aureus, Bacillus subtilis; able to produce b-galactosidase; with antioxidant activity levels
higher than 90%; with hydrophobicity activity and autoaggregation ability (evaluated by adhesion test,
where all the strains presented adhesion to mice ileal epithelial cells). These ﬁndings are relevant and the
strains are recommended for further in vivo studies as well as for potential therapeutic applications.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Probiotics are livemicroorganismswhich, when administered in
suitable doses, provide beneﬁts to human and animal health [1]. To
act in a positive way, probiotics need to be alive to create a sym-
biotic balance in the host's digestive tract [2], what emphasizes the
importance of the microbial viability during the gastrointestinal
transit, mainly in case of oral administration.
Microbial survival rate depends on the administration regimen,
thereby the use of synbiotic matrices for probiotic application and
maintenance of microbial viability has become signiﬁcant [3]. A
well known matrix for distribution of probiotics is the keﬁr, a fer-
mented milk obtained by incubation of milk with keﬁr grainsiros, Dois Irm~aos 52171-900,
rto).(protein and polysaccharide matrix containing bacteria and yeasts)
[4].
Microorganisms in the keﬁr grains proliferate and produce en-
zymes and other biogenic elements causing physicochemical
changes in the environment. For this reason, keﬁr has been
increasingly applied to medical beneﬁts, since it represents a great
source of natural probiotics and can be easily digested. Another
particular characteristic of keﬁr is that its grains can be recovered
after fermentation, making the process proﬁtable [5].
Among themost common probiotics used, some species of lactic
acid bacteria of the genus Lactobacillus and Biﬁdobacterium and the
yeast Saccharomyces boulardii have been often reported [6]. Yeasts
are particularly promising because they are not affected by anti-
bacterial agents [7], and this property is relevant since some ther-
apies combine the administration of probiotics with antibiotics in
the treatment of gastrointestinal infections. The use of yeasts is also
advantageous because their genetic material can not be transferred
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Yeasts have long been considered safe for applications [9], and
their beneﬁcial effects include competitiveness for nutrients, better
cell adhesion ability (in consequence of its size), production of
antagonistic compounds, immunomodulation, cholesterol assimi-
lation, toxin elimination and then neutralization of pathogenic
bacteria [10e13].
Saccharomyces boulardii has been the only yeast commercialized
worldwide as probiotic for humans, but some authors have sug-
gested other species or genera, based essentially on in vitro assays
and on clinical trials [8,11,14]. Further, it has been discussed that
there is a lack of concrete data about whether other yeast strains
(particularly S. cerevisiae) possess probiotic properties [15,16].
Different in vitro systems [17] have been preferentially used to
evaluate the gastrointestinal tolerance of probiotic strains [18] and
the microbial viability along the digestive tract [19]. For this reason,
€Otles et al. [20] enumerated generally required probiotic properties
as following: adherence to cells; exclusion or reduction of patho-
genic adherence; persistence and multiplicity; production of acids,
peroxide, and bacteriocins antagonistic to pathogen growth; to be
non-invasive, non-carcinogenic, and nonpathogenic; capability to
form a normal and balanced intestinal ﬂora.
To our best knowledge, only a small number of reports have
focused on the potential of probiotic yeasts to survive the transit
through the gastrointestinal tract [21,22]. Thus, this study aimed to
evaluate probiotic characteristics of yeast strains obtained after
in vitro simulation of digestion of keﬁr-fermented milk.2. Material and methods
2.1. Fermented milk
Keﬁr grains were obtained from a private household located in
Recife, Pernambuco, Brazil. They werewashedwith ultrapurewater
and inoculated in UHT milk. The grains were separated from the
fermented milk by ﬁltering them through a sieve, and thenwashed
for later use. This fermented milk was made by adding 5% (w/w)
keﬁr grains as inoculum. After incubation at 20 ± 2 C for 45e48 h,
aliquots were collected, at random intervals, and the pH was
monitored until reaching the value of 4.5. The grains were then
separated from the fermented milk by ﬁltration through a plastic
sieve and washed with ultrapure water before the next culture
incubation.2.2. In vitro digestion of keﬁr-fermented milk
The in vitro simulation of human digestion was based on the
method of Saito et al. [23]. To simulate the digestion, 10 mL of the
fermented milk was diluted 1:1 in a sterile electrolyte solution
containing 16.2 g/L NaCl, 2.2 g/L KCl, 0.22 g/L CaCl2, 1.2 g/L NaHCO3;
added of 0.6% (w/v) pepsin (Sigma-Aldrich, St. Louis, USA) and
further incubated for 5 min at 37 C. The pH was adjusted to 2.0 by
adding different volumes of 1 mol/L HCl and 5 mol/L HCl solutions,
for tight pH control. After 120 min of incubation, 1.5 mL were
harvested by centrifugation at 14.560  g for 5 min at 4 C (Hermle
Labortechnik, Wehingen, Germany) and then washed twice with
sterile PBS buffer pH 7.4 and resuspended with 1.5 mL of 1% (w/v)
bile salts (Merck, Darmstadt, Germany) in PBS buffer pH 8.
The solution was ﬁnally diluted in an artiﬁcial duodenal secre-
tion (pH 8.0) consisting of: PBS buffer, 0.3% (w/v) bile salts and 0.1%
(w/v) pancreatin (Sigma-Aldrich, St. Louis, USA). After 90 min of
incubation at 37 C, a 100 mL aliquot was pipetted out, serially
diluted into 0.1% peptone water solution and spread-plate on MRS
agar to determine the CFU/mL.2.3. Puriﬁcation and identiﬁcation of yeasts resistant to in vitro
digestion
After the growth period, 28 microorganism colonies, resistant to
in vitro digestion procedures, were collected from each Petri dish,
cultured by pour-plate method and incubated at 37 C for 48 h in
MRS medium. This procedure was done twice in order to purify the
colonies, which were subjected to Gram staining and classiﬁed as
yeasts. The culture media Sabouraud dextrose broth (Himedia,
Mumbai, India) and Sabouraud dextrose agar (Merck, Darmstadt,
Germany) were chosen for the subsequent assays.
The identiﬁcation of yeast species was done at the Department
of Mycology, Federal University of Pernambuco, Recife, Brazil, an
afﬁliate member of the World Federation for Culture Collections
(WFCC), where the yeasts were subjected to taxonomic character-
ization according to Barnett et al. [24].
The yeasts were identiﬁed as Saccharomyces cerevisiae and one
of them was randomly chosen for molecular identiﬁcation. The
molecular analysis was based on the following steps: 1) From the
Indicating FTA micro card (GE Healthcare, USA) containing the ScD
sample, a 2 mm punch was collected for the puriﬁcation of the
nucleic acids, which were puriﬁed using the FTA Puriﬁcation Re-
agent (GE Healthcare, USA). 2) After DNA puriﬁcation, the PCR was
performed using the universal forward primer (27F - AGAGTTT-
GATCMTGGCTCAG) and the universal reverse primer (1492R -
TACGGYTACCTTGTTACGACTT). 3) The PCR products were puriﬁed
and analyzed in agarose gel. 4) Sequencing was performed using
the BigDye Terminator 3 kit (Applied Biosystems, USA) and the
fragments were sequenced on the 3730XL DNA Analyzer (Applied
Biosystems, USA). 5) The generated sequences were aligned using
the Sequencher 5.0 software (GeneCodes, USA), to obtain the
consensus sequence. The consensus sequences were aligned using
the BLAST database. All these procedures were carried out by the
company STAB VIDA (Oeiras, Portugal).
2.4. Antagonistic activity
The spectrum of antagonistic activity of yeasts was determined
by the spot-on-the-lawn method, according to Tulini et al. [25]. The
indicator strains used, obtained from our culture collection, were
dangerous pathogenic bacteria: Klebsiella pneumoniae ATCC29665
(Gram negative, encapsulated, facultative anaerobic) and Pseudo-
monas aeruginosa ATCC27853 (Gram negative, aerobic); and
opportunistic bacteria: Enterococcus faecalis ATCC 6057 (Gram
positive, commensal in the digestive tract, aerobic), Bacillus subtilis
ATCC 6633 (Gram positive, ability to form spore, aerobic), Bacillus
cereus ATCC 33019, (Gram positive, ability to form spore, facultative
aerobic), Staphylococcus aureus ATCC 6538 (Gram positive, present
in mucosal membranes, aerobic) and Listeria innocua ATCC 33090
(Gram positive, facultative anaerobic). These strains were chosen
for their wide variety of physiological characteristics (which differ
each other), providing a broad estimate of the antagonistic action of
the yeasts studied. Five microliters of an overnight culture of each
yeast strain grown in Sabouraud dextrose broth was spotted on
ﬁlter paper discs (6 mm) on Sabouraud dextrose agar plates. After
incubation at 37 C for 72 h under aerobic conditions, the plates
were overlaid with 7 mL of soft BHI agar (0.8% w/v bacteriological
agar, Himedia) seeded with the indicator strain (106 CFU/mL), fol-
lowed by incubation at 37 C for 24 h. Inhibition halos (7 cm)were
indicative of susceptibility of the indicator strain.
2.5. Antioxidant activity
To evaluate the antioxidant activity, the percentage rate of
reduction of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical was
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modiﬁcations as suggested by Sousa et al. [26]. Brieﬂy, 1 mL of the
yeast culture in Sabouraud dextrose was harvested by centrifuga-
tion (14.560  g for 5 min at 4 C), washed twice with a sterile
solution of PBS pH 7.4 and the resulting pellet resuspended in 1 mL
of the same solution. The cell suspension (800 mL) was transferred
into a new tube, where 1 mL of a DPPH solution (0.2 mmol/L in
methanol) was afterwards added. The mix was vortexed and then
incubated for 30 min at room temperature in darkness. The reac-
tion tubes were centrifuged (14.560  g for 5 min at 4 C) and
300 mL of the supernatant were transferred into 96-well plates in
order to measure the absorbance at 517 nm (A517). The percentage
of reduction of DPPH was calculated according to Equation (1):
%AA ¼ f½Absi  ðAbss  AbsbÞ=Absig  100 (1)
where Absi is the initial absorbance (methanolic solution þ DPPH),
Abss is the absorbance of the mix (DPPH þ sample) and Absb is the
absorbance value of the blank sample.
The percentage of scavenging of DPPH was experimentally
conﬁrmed as directly proportional to the OD600 of the cell solution
used. The initial OD600 was measured for each culture and stan-
dardized to OD600 ¼ 1.00.
The results are presented in accordancewith the classiﬁcation of
Gil-Rodríguez et al. [16]: low activity (between 20 and 30%), good
activity (between 30 and 40%), very good activity (between 40 and
50%) and excellent activity (percentage reduction of DPPH higher
than 50%).
2.6. b-galactosidase activity
The o-nitrophenyl-b-D-galactopyranoside (ONPG) substrate
(Sigma-Aldrich, St. Louis, USA) was used to determine the b-
galactosidase activity as described by Nagy et al. [27], with modi-
ﬁcations. Cell-free extracts were prepared by sonication (sonicator
Bandelin electronic, Berlin, Germany) to disrupt the cells. Brieﬂy,
1 mL of overnight yeast cultures grown in Sabouraud broth were
harvested by centrifugation (14.560  g for 10 min at 4 C) washed
twice with 0.1 mol/L phosphate buffer, pH 7.0, and resuspended in
the same buffer. The cell suspension was sonicated at approxi-
mately 30% amplitude during 4 min, in intervals of 30s on and 30s
off. Cell debris was separated by centrifugation at 14.560  g for
10 min at 4 C. Cell extracts were kept on ice until incubation (for
30 min at 37 C).
The reaction mixture was composed of 50 mL of the sample and
50 mL of ONPG at a concentration of 3 mmol/L dissolved in 0.1 mol/L
phosphate buffer, pH 7.0. The reaction was stopped by addition of
200 mL of 0.1 mol/L sodium carbonate. The absorbance of the
samples was measured at 405 nm. A standard curve of o-nitro-
phenol (ONP, Sigma-Aldrich, St. Louis, USA) was obtained using
known concentrations of ONP, from 0.05 to 2 mmol/mL at intervals
of 0.05 mmol/mL, calculated using an extinction coefﬁcient of
4.0143 mmol/cm. One enzymatic unit was deﬁned as speciﬁc ac-
tivity (U/mg protein): 1 U is equivalent to 1 mmol of ONP produced
per minute.
2.7. Autoaggregation assay
A preliminary screening of the autoaggregation ability and
surface hydrophobicity was performed to identify potentially
adherent strains. As described by Meira et al. [28], yeast strains
were harvested by centrifugation (14.560  g for 10 min at 4 C),
washed twice and resuspended in 0.1 mol/L phosphate buffer (pH
7.2). Aggregation assays were performed at 20e25 C in 0.5 mol/L
phosphate buffer (pH 7.2). In all assays, the initial concentration ofmicroorganisms was standardized to OD600nm ¼ 1, approximately.
The autoaggregation assay was performed as follows: yeast cell
suspensions (2 mL) were incubated at 37 C and absorbance values
(at 600 nm) of the upper layer were measured at different time
intervals (2, 4 and 24h) in a UV-Vis spectrophotometer 2000 UV
(Bel Photonics, Osasco, Brazil). The percentage of aggregation (%A)
was calculated according to Equation (2) [29]:
%At ¼ ½1 ðODt=ODiÞ  100 (2)
where ODi is the initial optical density of the microbial suspension
and ODt is the optical density at the time t.2.8. In vitro cell surface hydrophobicity
The isolates were screened for their cell surface hydrophobicity
using the microbial adhesion to hydrocarbons (xylene) method,
described by Rosenberg et al. [30]. Brieﬂy, the yeasts isolates were
grown overnight at 37 C in Sabouraud dextrose broth and washed
with sterile phosphate buffered saline solution (PBS, pH 7.2), har-
vested and resuspended in the same buffer. The suspension was
then adjusted to approximately 108 CFU/mL (OD600; A1). Aliquots
(3 mL) of the yeast suspensions were added to 1 mL of xylene,
mixed by vortexing for 60 s, and kept for 2 h at 37 C, until the
aqueous phase was carefully removed and the absorbance
measured at 600 nm (A2) [28]. The Hydrophobicity Index (HPBI)
was calculated according to Equation (3):
%HPBI ¼ ½ðA1 A2Þ=A1  100 (3)
Isolates with a HPBI greater than 70% were arbitrarily classiﬁed
by Pringsulaka et al. [31] as highly hydrophobic; isolates with HPBI
between 50 and 70% were classiﬁed as moderate hydrophobic; and
isolates with HPBI lower than 50% were classiﬁed as lowly hydro-
phobic. High hydrophobicity has been suggested as indicator of
good adhesion capacity.2.9. Epithelial cell adherence assay
The yeast adhesion to mice ileal epithelial cells was assessed by
using eight-week-old male and female Swiss albino mice (30e40 g
body weight). They were fed with a conventional balanced diet
(16% protein, 56% carbohydrate, 2% fat, 5.3% cellulose, and 5% vi-
tamins and minerals) and tap water ad libitum to improve their
adaptation. Three to four mice were housed per polycarbonate
cage, with softwood chips as bedding, in an air-conditioned room at
23e25 C, air humidity of 50e60% and under a 12 h light/dark cycle.
Intestines were collected immediately after euthanasia according to
the ethical principles of animal experimentation of COBEA (Bra-
zilian College of Animal Experimentation) and approved by the
Animal Studies Committee of Federal University of Pernambuco
(protocol number 23076.017009/2012-13).
Epithelial cells were prepared as described by Annika et al. [32]
and improved by Kumar and Kumar [33]. A small segment of ileum
from female and male Swiss albino mice Mus musculus, was
opened, washed twice with sterilized PBS (0.1 mol/L, pH 7.2) and
incubated in PBS at 4 C for 30 min to remove the surface mucus.
Epithelial cells were scraped off with the edge of amicroscope slide,
suspended in PBS, and microscopically examined to ensure the
removal of adherent bacteria. Further, 1 mL of each yeast inoculum
(108 CFU/mL) and the epithelial cell suspension were mixed,
incubated at 37 C and at 40 rpm of agitation for 30 min. The
attachment of yeast cells was studied microscopically after the
Gram stained preparations.
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Experimental data, microorganism counting and frequency (%)
tables are shown as the mean of multiple assays (±standard devi-
ation, when indicated). Analyses were performed by the software
Microsoft Excel 2010 (Microsoft, Redmond, USA).3. Results
3.1. Identiﬁcation of yeasts resistant to in vitro digestion
The colony count of the fermented milk showed approximately
10 log10 CFU/mL and 2 log10 CFU/mL before and after the in vitro
digestion process, respectively. Among the resistant strains, 28
were isolated (Fig. 1) to be further evaluated for their morpholog-
ical and physiological characteristics. All the strains were identiﬁed
as Saccharomyces cerevisae and named as: ScA, ScA1, ScB, ScB1, ScC,
ScD, ScE, ScF, ScG,ScH, ScI, ScJ, ScK, ScL, ScM, ScN, ScO, ScP, ScQ, ScR,
ScS, ScT, ScU, ScV, ScW, ScX, ScY, ScZ.
The strain ScD was randomly selected for molecular taxonomic
identiﬁcation, which conﬁrmed the species identiﬁcation based on
99% identity of ITS sequences, compared to database sequences
(GenBank accession no. CP006424.1).3.2. Antagonistic activity
Table 1 presents the antagonistic activities of the yeasts studied.
All the S. cerevisiae species inhibited K. pneumoniaeATCC 29665 and
82.1%, 53.5% and 25% of them presented antagonism against
P. aeruginosa ATCC27853, S. aureus ATCC 6538 and B. subtilis ATCC
6633, respectively. In total, 17 yeasts were able to inhibit at least
three indicator strains, 8 yeasts presented antagonism against two
indicator strains and 2 yeasts inhibited at least one of them. The
antagonistic activity of the strain ScL was themost relevant because
it inhibited 4 indicator strains, whilst the highest antagonism was
found for the strain ScO, which produced a halo of inhibition of
47.7 ± 8.5 against K. pneumoniae. No antagonistic activity wasFig. 1. Counting of microorganisms before (dark grey), during (grey) and after (white)
the in vitro digestion. In the center of the diagram are represented the number of
microorganisms isolated and evaluated in the present study.observed against E. faecalis ATCC 6057, B. cereus ATCC 33019 and
L. innocua ATCC 33090.
3.3. Antioxidant activity
Different levels of antioxidant activity were found for the strains
tested (Table 2). Among the 28 yeasts analyzed, 5 strains (17.85%)
showed good activity (levels between 30 and 40%); 11 strains
(39.3%) exhibited very good activity (levels between 40 and 50%)
and 12 strains (42.85%) showed excellent activity (percentage
reduction of DPPH higher than 50%); among the last group, ScJ and
ScZ presented antioxidant activity higher than 90% (Table 2). The
lowest and highest activities were observed for the strains ScN
(34.83 ± 0.01%) and ScZ (114.16 ± 0.01%), respectively.
3.4. b-galactosidase activity
According to themethods used, all the yeasts, after cell breakage
by sonication, exhibited intracellular b-galactosidase activity
(Fig. 2). Lactose was hydrolyzed by the yeast extracts in different
levels, and depending on the strain, whose values ranged from 1.25
to 5.32 U/mL, with the highest value obtained for the strain SCG.
3.5. Autoaggregation assay
Yeast cells are considered relatively large and heavy. For this
reason, since the second hour of test, it was possible to observe high
levels of precipitation. The percentage of autoaggregation showed
high variability among the strains, with percentages higher than
60%, ranging from 61.4 ± 0.1% for ScA to 96.2 ± 0.2% for ScO. As
shown in Fig. 3, since the fourth hour, the strains ScP and ScZ
showed 100% of aggregation, whilst twenty-three strains (82.1%),
among all studied, took 24 h to reach the same level of aggregation.
3.6. Cell surface hydrophobicity
All the tested strains showed moderate or high hydrophobicity.
In Table 3, the strain ScR showed a moderate rate between 50 and
70%, while the other strains exhibited high hydrophobicity. Eight of
them (28.5%) showed a percentage from 80 to 90%, and nineteen of
them (67.9%) showed rates higher than 90%. The lowest value was
obtained for the ScR (63.36 ± 1.91%), and the highest for the ScB
(96.08 ± 1.48%).
3.7. Epithelial cell adherence assay
Fig. 4 shows a signiﬁcant yeast adherence of all the strains to
intestinal cells. A commercial Saccharomyces cerevisiae yeast was
used as negative control for not being able to adhere to epithelial
cells (data not shown). These results conﬁrm what has been dis-
cussed in the previous sections, that hydrophobicity and autoag-
gregation all together support the yeast adherence to epithelial
cells.
4. Discussion
The yeasts studied were suggested as probiotic because their
source of keﬁr, which is already known as probiotic complex and
their resistance to the harsh conditions of the gastrointestinal tract.,
One of the most desirable properties of probiotic yeasts is their
antagonistic activity against adherence and translocation of path-
ogens [34]. The strains studied here showed antagonistic activity
against Gram negative (K. pneumoniae and P. aeruginosa) and Gram
positive (S. aureus and B. subtilis) bacteria. Binetti et al. [15] evalu-
ated the antagonistic activity of yeasts from autochthonal cheese
Table 1
Antagonistic activity of S. cerevisiae strains against pathogens after in vitro digestion of keﬁr-fermented milk.
Indicator strains with IZDa
Yeast
Strain
Klebsiella pneumoniae
ATCC 29665
Pseudomonas aeruginosa
ATCC 27853
Staphylococcus aureus
ATCC 6538
Bacillus subtilis
ATCC 6633
Enterococcus faecalis
ATCC 6057
Listeria innocua
ATCC 33090
Bacillus cereus
ATCC 3019
ScA 22.7 ± 2.6 28.9 ± 4.0 __ 19.8 ± 0.1 __ __ __
ScA1 15.9 ± 0.0 33.8 ± 4.4 __ __ __ __ __
ScB 21.1 ± 2.3 25.41 ± 0.0 __ 21.9 ± 1.8 __ __ __
ScB1 26.9 ± 5.8 31.5 ± 1.4 __ 15.5 ± 0.0 __ __ __
ScC 21.2 ± 5.6 22.6 ± 3.8 __ __ __ __ __
ScD 22.8 ± 6.2 15.4 ± 5.3 __ 17.4 ± 0.9 __ __ __
ScE 16.7 ± 2.1 16.9 ± 0.0 __ 19.5 ± 1.3 __ __ __
ScF 15.7 ± 0.0 32.2 ± 0.0 __ 20.4 ± 2.2 __ __ __
ScG 18.8 ± 0.0 __ __ __ __ __ __
ScH 20.8 ± 0.1 19.3 ± 2.9 __ __ __ __ __
ScI 28.9 ± 0.0 30.9 ± 0.0 23.8 ± 0.0 __ __ __ __
ScJ 23.8 ± 0.0 38.9 ± 0.0 __ __ __ __ __
ScK 19.1 ± 0.9 __ 16.46 ± 0.0 __ __ __ __
ScL 27.6 ± 0.6 13.2 ± 0.1 17.2 ± 5.4 15.2 ± 1.7 __ __ __
ScM 34.9 ± 0.0 __ 18.8 ± 8.0 __ __ __ __
ScN 29.5 ± 0.0 __ __ __ __ __ __
ScO 47.7 ± 8.5 20.0 ± 0.0 18.5 ± 5.3 __ __ __ __
ScP 21.5 ± 3.1 25.7 ± 9.6 26.4 ± 9.2 __ __ __ __
ScQ 19.3 ± 0.2 22.4 ± 9.8 23.1 ± 1.8 __ __ __ __
ScR 17.6 ± 2.0 21.6 ± 9.2 22.6 ± 3.4 __ __ __ __
ScS 27.1 ± 0.0 19.9 ± 6.0 18.8 ± 3.5 __ __ __ __
ScT 26.5 ± 2.2 29.9 ± 5.9 15.9 ± 1.1 __ __ __ __
ScU 30.7 ± 7.0 25.4 ± 1.4 35.0 ± 6.6 __ __ __ __
ScV 16.5 ± 1.9 14.5 ± 0.2 21.6 ± 1.4 __ __ __ __
ScW 18.5 ± 6.7 37.2 ± 2.2 29.9 ± 0.1 __ __ __ __
ScX 30.7 ± 2.7 27.7 ± 0.1 15.0 ± 0.1 __ __ __ __
ScY 24.0 ± 1.8 __ 29.9 ± 0.1 __ __ __ __
ScZ 26.1 ± 2.7 35.7 ± 1.2 __ __ __ __ __
IZD ¼ Inhibition Zone Diameter, e ¼ no inhibition.
a Values expressed as mean (mm) ± S.D. (n ¼ 3).
Table 2
Evaluation of the antioxidant activity of S. cerevisae strains observed after in vitro
digestion of keﬁr-fermented milk, according to the classiﬁcation of Gil-Rodrígues
et al. [16].
DPPH reduction activity
Percentage Yeast Strain
30e40% ScN, ScP, ScS,ScT, ScU
40e50% ScD, ScF, ScG, ScH, ScK, ScL, ScM, ScO, ScQ, ScR, ScY
50e60% ScA1, ScB, ScB1, ScI, ScV, ScX
60e90% ScE, ScW, ScA, ScC
>90% ScJ, ScZ
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monella enteritidis OMS-Ca and Staphylococcus aureus 76, although
they were unable to inhibit the growth of pathogenic microor-
ganisms. The same was veriﬁed by Perricone et al. [35] when
studied yeasts isolated from Altamura sourdough as functional
starter cultures for cereal based foods No antagonistic activity was
observed when 14 different strains of S. cerevisiae were tested
against Listeria monocytogenes, Yersinia enterocolitica, Escherichia
coli O157:H7 and Staphylococcus aureus.
Kourelis et al. [36] tested the antimicrobial activity of sterilized
supernatants from 4, 8, 16 and 24-h cultures obtained from dairy
and human yeast strains and veriﬁed that none of the 20 tested
strains were able to inhibit the growth of Clostridium tyrobutyricum,
Bacillus cereus, Clostridium sporogenes, Enterococcus faecalis,
Escherichia coli, Listeria monocytogenes, Staphylococcus aureus and
Yersinia enterocolitica. The antagonistic activity and the capacity to
produce different antimicrobial compounds are considered critical
characteristics for effective competitive exclusion of pathogens and
for probiotic beneﬁts [37], which emphasize the relevance of theprobiotic properties found in the present study.
The antioxidant activity observed in this study was higher than
previously reported. Gil-Rodriguez et al. [16], for example, evalu-
ated the probiotic properties of 59 yeast strains isolated from food
and beverage products, and found that only two of them (3.4%)
showed a percentage reduction of DPPH higher than 50%. Chen
et al. [38] evaluated the DPPH radical scavenging (expressed as
percentage of absorbance decrease) by using intact cells of 12
yeasts and observed antioxidant activity in the range of
4.25e46.78%. Food antioxidant activity promoted by probiotics has
been increasingly used in healthcare contexts since their presence
contribute to free radical scavenging. Since the strains reported in
this study showed considerable antioxidant activity, they are sug-
gested to improve the effectiveness of pharmacological and nutri-
tional compounds.
As source of enzymes, probiotics are beneﬁcial to the health of
the host for improving the utilization and absorption of nutrients
along the digestive tract. For example, b-galactosidase hydrolyzes
lactose into glucose and galactose, facilitating the transport of milk
components across the intestinal epithelium [39]. These ﬁndings
are signiﬁcant when compared to previous studies. Sourabh et al.
[40] performed a qualitative screening for b-galactosidase of 23
S. cerevisiae strains obtained from various traditional fermented
foods (chilra, babru, and bhaturu), alcoholic beverages (aara,
chhang, chuli, faasur, lugari) and traditional inocula of western
Himalayas (phab, dhaeli, khameer), however, none of the strains
was positive. Pennacchia et al. [41] isolated S. cerevisiae strains from
different food matrices (traditional salame ‘Tipo Napoli’; wine;
traditional Sopressata; natural starter culture for the production of
mozzarella di Bufala Campana; caciotta cheese and sour-dough) to
preliminary selection of a potential probiotic. The b-galactosidase
activity of ﬁve selected strains were evaluated by the API-ZYM test
Fig. 2. b-galactosidase activity of the cell extract (without cell debris) of S. cerevisae strains obtained after in vitro digestion of keﬁr-fermented milk.
Fig. 3. Autoaggregation percentage of S. cerevisae strains obtained after in vitro digestion of keﬁr-fermented milk, percentage after 2 h (dark grey), 4 h (light grey) and 24 h (grey).
Table 3
Evaluation of Hydrophobicity of S. cerevisae strains obtained after in vitro digestion of keﬁr-fermentedmilk, according to the classiﬁcation
of Pringsulaka et al. [30].
In vitro cell surface hydrophobicity
Percentage Strain
60e80% ScR
80e90% ScA, ScH, ScI, ScJ, ScP, ScT, ScV, ScX
>90% ScA1, ScB, ScB1, ScC, ScD, ScE, ScF, ScG, ScK, ScL, ScM, ScN, ScO, ScQ, ScS, ScU, ScW, ScY, ScZ
M.S.F. Lima et al. / Microbial Pathogenesis 110 (2017) 670e677 675(bio-Merieux, Marcy I'Etoile, France), but no activity was found. Our
ﬁndings are relevant because they present many probiotic strains
with intracellular b-galactosidase, able to digest lactose. Lactose
indigestion symptoms occur when undigested lactose passes
through the small intestine and is fermented by colonic bacteria,
resulting in the generation of hydrogen gas [39]. Probiotics with b-
galactosidase activity are important because they prevent
discomfort arising from intestinal fermentation [40].Adherence ability is essential to probiotic efﬁcacy, and for this
reason the analysis of autoaggregation and hydrophobicity are
necessary to evaluate potential probiotic yeasts. In our assays, after
2 h, the strains presented higher percentage of aggregation than
previously reported by Gil-Rodríguez et al. [16] when they inves-
tigated the autoaggregation ability of 53 S. cerevisae strains isolated
from varieties of grape, wine, apple must, grape must, Juglans regia
seeds, milk, mistela and quince jelly. Binetti et al. [15] isolated 4
Fig. 4. Microscopic view of the adhesion of S. cerevisae strains obtained after in vitro digestion of keﬁr-fermented milk with intestinal epithelial cells from Swiss albino mice, stained
by Gram's method. The arrow indicates the position of the adhered yeast: a) ScB, b) ScD, c) ScE, d) ScQ, e) ScV and f) ScZ.
M.S.F. Lima et al. / Microbial Pathogenesis 110 (2017) 670e677676S. cerevisae strains (from a total of 20 other strains) from cheese
starters and observed percentages of 37.9 ± 6.7%, 44.1 ± 2.4%,
45.3 ± 1.0% and 48.6 ± 17.5%, showing intermediate autoag-
gregation ability, following the classiﬁcation proposed by the au-
thors. Syal and Vohra [42] reported that autoaggregation ability
above 80% is considered strong, and this property has been related
to the ability to adhere to intestinal epithelial cells [15].
The surface hydrophobicity of the evaluated strains was signif-
icant when compared to previous reports. Binetti et al. [15] studied
the hydrophobicity of 20 autochthone strains isolated from milk
and cheese whey starters, and reported percentages ranging from
45 ± 3% to 85 ± 3%, with the highest value for the S. cerevisiae L1
(80 ± 1%). Syal and Vohra [42] evaluated the hydrophobicity of 7
yeast strains isolated from fermented Indian foods and found per-
centages between 32% and 68%. Low levels of hydrophobicity were
also found by Sourabh et al. [40] when they screened 23 yeast
strains and found only 9 of them with percentage above 50%
(59.65% was the highest). High hydrophobicity of the cell surface is
supposed to explain why certain strains exhibit slower elimination
kinetics from the gastrointestinal tract and also have different
health effects [43]. Nevertheless, a good correlation between hy-
drophobicity (in vitro assays) and intestinal adhesion (in vivo as-
says) was not always found, as previously reported [15].
At the same time, adhesion to intestinal epithelial cells is also animportant prerequisite for colonization of probiotic strains in the
gastrointestinal tract, preventing their immediate elimination by
peristalsis and providing a competitive environmental advantage
[34,44]. Cell adhesion is due to non-speciﬁc physical interactions
between two surfaces, which enable speciﬁc interactions between
adhesins and complementary receptors [42]. Yeasts from keﬁr
grains were shown to enhance aggregation and adhesion of lactic
acid bacteria to the epithelial cells [18,45]. Verstrepen and Klis [46]
reported that the ability of the yeasts to adhere to intestinal
epithelial cells is probably due to their capacity to rapidly adapt to
new habitats and form bioﬁlms. Kourelis et al. [36] concluded, after
studying the yeasts Candida sp. and Saccharomyces sp. from Feta
cheese, that most of the yeasts able to adhere to the intestinal
epithelium are pathogenic, such as Candida sp. These facts
contradict our ﬁndings, since we have found that non-pathogenic
Saccharomyces cerevisiae strains, isolated from milk fermented by
keﬁr, presented good levels of adherence to epithelial cells.
5. Conclusion
Saccharomyces cerevisiae strains obtained after in vitro digestion
of keﬁr-fermented milk showed interesting probiotic properties,
resistance to harsh conditions of digestion and to antimicrobial
agents. The strains studied should be considered potential
M.S.F. Lima et al. / Microbial Pathogenesis 110 (2017) 670e677 677probiotics because of their properties not yet reported for
S. cerevisiae as: antagonism to pathogenic microorganisms, anti-
oxidant activity, adhesion to epithelial cells and ability to digest
nutrients. Our ﬁndings should encourage further researches on the
application of these strains as food and feed supplements.
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